Placeholder Banner

BIO and CSBA Letter to Congress to Support One Health and Advance Animal Biotech

June 2, 2020

The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation directing the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop a Memorandum of Understanding (MOU) to streamline the regulatory oversight of animal biotechnology.

Elevating and prioritizing the relationship of living things through One Health strategies and modernizing America’s animal biotechnology regulatory approach are two policies Congress must address in any future COVID-19 legislation. Doing so will ensure we are ready for the next potential animal to human disease outbreak.

Download Full Comments Below
BIO/CSBA Letter to Congress
Discover More
BIO and the American Seed Trade Association submitted comments on USDA-APHIS' proposed exemptions of five types of genetic modifications a plant can contain and be exempt from regulations for the movement of organisms modified or produced through…
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill. 
BIO provides detailed comments in advance of the July 31, 2023 NIH Workshop, “Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.